Chinese pharmaceutical company Northeast Pharmaceutical Group plans to acquire 60% stake in a medicine company based in Dandong, China, through its subsidiary for CNY3.9m ($0.57m).

Venture capital firm Principia, along with the Principia Health Fund, has announced the acquisition of 70% stake in pharmaceutical company Trifarma.

Discover B2B Marketing That Performs

Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.

Find out more

"Venture capital firm Principia, along with the Principia Health Fund, has announced the acquisition of 70% stake in pharmaceutical company Trifarma."

All entities involved in the acquisition are based in Italy. The acquisition will enable Principia to launch new products in the Italian market.

Creador III’s affiliate Commelina has announced the acquisition of 22% stake in Indian healthcare and medical services provider Paras Healthcare for Rs2.75bn ($42.7m).

Creador is a private equity firm based in Malaysia.

GlobalData Strategic Intelligence

US Tariffs are shifting - will you react or anticipate?

Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.

By GlobalData

Pharmaceutical Technology Excellence Awards - Nominations Closed

Nominations are now closed for the Pharmaceutical Technology Excellence Awards. A big thanks to all the organisations that entered – your response has been outstanding, showcasing exceptional innovation, leadership, and impact.

Excellence in Action
Awarded the 2025 Pharmaceutical Technology Excellence Award for Business Expansion in Integrated Manufacturing, Upperton Pharma Solutions is rapidly expanding its UK GMP and sterile manufacturing footprint. Find out how Upperton’s integrated CDMO model helps pharma companies move from early development to clinical and niche commercial supply with fewer handovers and faster timelines.

Discover the Impact